SIMRIS B Stock Overview
Develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Simris Group AB (PUBL) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.17 |
| 52 Week High | kr0.40 |
| 52 Week Low | kr0.096 |
| Beta | 0.68 |
| 1 Month Change | 49.14% |
| 3 Month Change | -17.62% |
| 1 Year Change | -52.21% |
| 3 Year Change | -79.55% |
| 5 Year Change | -96.61% |
| Change since IPO | -98.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| SIMRIS B | SE Personal Products | SE Market | |
|---|---|---|---|
| 7D | -13.3% | -1.4% | -0.8% |
| 1Y | -52.2% | 22.8% | 14.3% |
Return vs Industry: SIMRIS B underperformed the Swedish Personal Products industry which returned 21.2% over the past year.
Return vs Market: SIMRIS B underperformed the Swedish Market which returned 14.2% over the past year.
Price Volatility
| SIMRIS B volatility | |
|---|---|
| SIMRIS B Average Weekly Movement | 21.2% |
| Personal Products Industry Average Movement | 4.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 12.9% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: SIMRIS B's share price has been volatile over the past 3 months.
Volatility Over Time: SIMRIS B's weekly volatility has increased from 13% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 9 | Alexis McIntosh | simrisalg.se |
Simris Group AB (PUBL) develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally. It offers skincare products and pharmaceuticals; food ingredients; and Algae Omega-3, an omega-3 EPA and DHA line under the SIMRIS brand name. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
Simris Group AB (PUBL) Fundamentals Summary
| SIMRIS B fundamental statistics | |
|---|---|
| Market cap | kr60.22m |
| Earnings (TTM) | -kr36.81m |
| Revenue (TTM) | kr4.23m |
14.2x
P/S Ratio-1.6x
P/E RatioIs SIMRIS B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIMRIS B income statement (TTM) | |
|---|---|
| Revenue | kr4.23m |
| Cost of Revenue | kr2.20m |
| Gross Profit | kr2.04m |
| Other Expenses | kr38.85m |
| Earnings | -kr36.81m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 48.13% |
| Net Profit Margin | -869.41% |
| Debt/Equity Ratio | 0% |
How did SIMRIS B perform over the long term?
See historical performance and comparison